Abstract Submission:Abstract submission has been suspended in light of the need to postpone the conference. We will reopen the submission period later this year.
Abstract submission topics:
Replication and Therapeutics
Immunity and Vaccines
Delegates who would like to present their work at the meeting as a poster or oral presentation, are invited to submit an abstract for consideration by the Regional Organizing and Scientific Advisory Committees. Abstracts are accepted on a wide range of themes according to the abstract submission topics listed above.
The corresponding topic must be selected to ensure correct scoring of the abstract. The content of the abstract must be topic related. The papers will be peer-reviewed and selected for oral or poster presentation.
Abbreviations should be indicated in parentheses following their first mention in the text. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
Conflict of Interest Policy:It is the intent of the 23rd International Conference on Kaposi’s Sarcoma Herpesvirus (KSHV) and Related Agents to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during abstract submission. All speakers should include a disclosure slide as the first slide in the presentation, disclosing any potential conflicts of interest.
Before beginning your abstract submission, please collect the following:
Presenting authors contact information and affiliation
Co-Authors names, affiliations and email
Principal Investigator/Lab Head name, email and affiliation
Abstract Submission Guidelines
Please review the Abstract Submission Example Document here. This document provides instructions for formatting and can be used as a template.
The abstract submission must be formatted to the A5 page size.
Font must be in Times New Roman 11pt.
The abstract body text has a 300 word count limit.
Select your presentation preference: oral or poster presentation or no preference.
Include all authors and affiliations in submission, including the submitting author, any co-authors, and Principal Investigator/Lab Head.
All abstracts must be submitted and presented in English with spelling and grammar of a quality suitable for publication.
All submissions will print the exact way they are submitted. They must be submitted as Microsoft Word files.
Abstracts must be submitted by the presenting author, advisors may not submit an abstract for another person.
Posters have a maximum size of 120x120cm (roughly 47×47”).
All submissions are reviewed by the conference program committee.
Proposals constituting sales pitches for products or services will not be considered.
Any submissions not chosen for an oral presentation will receive a poster presentation.
Authors will be notified of the abstract acceptance/rejection by mid May.
Submitting an Abstract
All presenting authors must be registered for the meeting by April 12, 2021.
Fill out the abstract form that is linked at the top right-hand side of this page. Final decisions about oral vs. poster presentations will be made after abstract review by the Scientific Advisory Committee.
The third and final step is to review your submission and submit. All submissions are final upon completion of the abstract form. You will receive a confirmation email with your unique Abstract ID number after your abstract submission has been successfully received. If you do not receive this confirmation email within 72 hours, please contact Tischan.
If you have any questions about abstract submissions, please contact the KSHV 2020 Abstracts Team: